Accelerant 控股
估值 各估值倍数与自身5年区间的对比
同业对比 Insurance Brokers
| 公司 | 市值 | 市盈率(TTM)i | 市净率i | 股息率i |
|---|---|---|---|---|
| Accelerant 控股 (ARX) | 4.29B | -3.13 | 5.98 | 0.00% |
| Marsh (MRSH) | 89.56B | 22.53 | 6.10 | 2.01% |
| Arthur J. Gallagher (AJG) | 65.33B | 42.27 | 2.75 | 1.06% |
| Aon PLC (AON) | 62.06B | 16.13 | 6.47 | 1.04% |
| Willis Towers Watson (WTW) | 29.30B | 19.53 | 3.81 | 1.19% |
| Brown & Brown (BRO) | 23.22B | 22.17 | 1.85 | 0.93% |
StockVane 追踪范围内同行业的其他公司。
Morningstar
当前股价低于晨星合理价值估算40.5%。
合理价值
While Accelerant Holdings may seem inexpensive after its substantial price decline over the past year, we've limited its rating to 3 stars to account for the possibility that it may represent a value trap. The stock currently trades at a 29% discount to our quantitative fair value estimate of $27.74 per share; however, caution is warranted due to this estimate's high uncertainty rating.
The company's balance sheet increases our estimated fair value. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. For example, the firm's EBITDA/interest coverage ratio of -12.8 lies in the bottom 10% compared with global peers. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. We believe this is a sign that shares could be undervalued.
Alternatively, the firm's valuation metrics are potentially concerning. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of 16.8%, a core component of valuation, falls in the bottom 20% compared with peers globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which, despite our favorable price/fair value ratio, is a negative attribute.
经济护城河
With its quantitative economic moat rating of none, this business is unlikely to consistently outearn its cost of capital without structural protection from competition. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
作者:Quantitative Equity Report
报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
Accelerant 控股 讨论区 0 条评论